PETER BAILEY: Open Payments
NPI 1871974808 · CAYCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 69 payments from 17 companies in 2025. Trend: 2023 $1,311 · 2024 $1,437 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| ABBVIE INC. | 12 | $164 |
| PFIZER INC. | 8 | $159 |
| Lilly USA, LLC | 11 | $144 |
| Novo Nordisk Inc | 6 | $117 |
| Exact Sciences Corporation | 5 | $89 |
| Amgen Inc. | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $29 |
Products named: MOUNJARO, BREZTRI, NURTEC ODT, Cologuard Collection Kit, QULIPTA, Ozempic, AIRSUPRA, Wegovy.
Industry payments across SC — which companies pay providers there.
